316 related articles for article (PubMed ID: 8547610)
21. Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease.
Staratschek-Jox A; Kotkowski S; Belge G; Rüdiger T; Bullerdiek J; Diehl V; Wolf J
Am J Pathol; 2000 Jan; 156(1):209-16. PubMed ID: 10623669
[TBL] [Abstract][Full Text] [Related]
22. Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology Group.
Takenaka T; Mikuni C; Miura A; Sasaki T; Suzuki H; Hotta T; Hirano M; Fukuhara S; Sugiyama H; Nasu K; Dohi H; Kozuru M; Tomonaga M; Tajima K; Niimi M; Fukuda H; Mukai K; Shimoyama M
Jpn J Clin Oncol; 2000 Mar; 30(3):146-52. PubMed ID: 10798542
[TBL] [Abstract][Full Text] [Related]
23. Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin's disease: case report and literature review.
Adiga GU; Abebe L; Wiernik PH
Am J Hematol; 2003 Apr; 72(4):267-73. PubMed ID: 12666139
[TBL] [Abstract][Full Text] [Related]
24. Encoded latent membrane protein 1 of Epstein-Barr virus on follicular dendritic cells in residual germinal centres in Hodgkin's disease.
van Gorp J; Jacobse KC; Broekhuizen R; Alers J; van den Tweel JG; de Weger RA
J Clin Pathol; 1994 Jan; 47(1):29-32. PubMed ID: 8132805
[TBL] [Abstract][Full Text] [Related]
25. Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan.
Miyagi J; Toda T; Uezato H; Ohshima K; Miyakuni T; Takasu N; Masuda M
Int J Hematol; 2002 Jan; 75(1):78-84. PubMed ID: 11843296
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
[TBL] [Abstract][Full Text] [Related]
27. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
[TBL] [Abstract][Full Text] [Related]
28. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease.
Reynolds DJ; Banks PM; Gulley ML
Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953
[TBL] [Abstract][Full Text] [Related]
29. BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
Diehl V; Franklin J; Hasenclever D; Tesch H; Pfreundschuh M; Lathan B; Paulus U; Sieber M; Rueffer JU; Sextro M; Engert A; Wolf J; Hermann R; Holmer L; Stappert-Jahn U; Winnerlein-Trump E; Wulf G; Krause S; Glunz A; von Kalle K; Bischoff H; Haedicke C; Duehmke E; Georgii A; Loeffler M
J Clin Oncol; 1998 Dec; 16(12):3810-21. PubMed ID: 9850026
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
Oudejans JJ; Jiwa NM; Meijer CJ
J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
[TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
[TBL] [Abstract][Full Text] [Related]
33. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
[TBL] [Abstract][Full Text] [Related]
34. Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M; Tesch H; Pfistner B; Rueffer U; Lathan B; Brosteanu O; Paulus U; Koch T; Pfreundschuh M; Loeffler M; Engert A; Josting A; Wolf J; Hasenclever D; Franklin J; Duehmke E; Georgii A; Schalk KP; Kirchner H; Doelken G; Munker R; Koch P; Herrmann R; Greil R; Anselmo AP; Diehl V
J Clin Oncol; 2002 Jan; 20(2):476-84. PubMed ID: 11786577
[TBL] [Abstract][Full Text] [Related]
35. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
Canellos GP
Semin Oncol; 1990 Feb; 17(1 Suppl 2):2-6. PubMed ID: 1689509
[TBL] [Abstract][Full Text] [Related]
36. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease.
Herbst H; Steinbrecher E; Niedobitek G; Young LS; Brooks L; Müller-Lantzsch N; Stein H
Blood; 1992 Jul; 80(2):484-91. PubMed ID: 1320954
[TBL] [Abstract][Full Text] [Related]
37. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-12 expression in human lymphomas and nonneoplastic lymphoid disorders.
Schwaller J; Tobler A; Niklaus G; Hurwitz N; Hennig I; Fey MF; Borisch B
Blood; 1995 Apr; 85(8):2182-8. PubMed ID: 7718889
[TBL] [Abstract][Full Text] [Related]
39. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus.
Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G
Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
